SpringWorks Therapeutics drug Ogsiveo is now FDA-approved for treating desmoid tumors, a type of tumor affecting connective tissue. The regulatory decision makes the pill the first therapy ...

Ogsiveo (nirogacestat) has been cleared as an oral, first-line therapy for adult patients with progressing desmoid tumours who ... of Memorial Sloan Kettering Cancer Centre.

Dublin, May 08, 2025 (GLOBE NEWSWIRE) -- The "Desmoid Tumors - Pipeline Insight, 2025" report has been added to ResearchAndMarkets.com's offering. This report offers a comprehensive examination of ...